Does PlexusDx provide reminders or tracking for injection timing
Mounjaro is also approved for weight loss in adults with type 2 diabetes, making it a dual-purpose treatment
Reference: Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials by Sunil V Badve, Anika Bilal, Matthew M Y Lee, Naveed Sattar, Hertzel C Gerstein, Christian T Ruff, John J V McMurray, Peter Rossing, George Bakris, Kenneth W Mahaffey, Johannes F E Mann, Helen M Colhoun, Katherine R Tuttle, Richard E Pratley and Vlado Perkovic, 25 November 2024, The Lancet Diabetes & Endocrinology
Flat base technology Designed to improve skin contact and comfort
As weight decreases and the body adapts, the overall effect on weight can become less pronounced, even if appetite remains controlled